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Abstract	
Aim:	
Preterm	 births	 and	 respiratory	 distress	 syndrome	 (RDS)	 are	 associated	with	 pulmonary	 vascular	 disease	
and	altered	myocardial	 function.	We	serially	assessed	up	to	one	year	of	age	the	effects	of	RDS	on	global	
and	 regional	 myocardial	 function	 of	 preterm	 infants,	 compared	 to	 preterm	 and	 term	 controls	 using	
conventional	echocardiography	parameters,	tissue	Doppler	velocities	and	deformation	analysis.		
Methods	and	results:	
120	 infants	 (30	 preterm	 (PT)	 with	 RDS,	 30	 PT	 controls	 without	 RDS,	 and	 60	 term	 controls)	 underwent	
conventional	and	tissue	Doppler	echocardiography	within	72	hours	of	birth,	at	corrected	term	age	for	the	
preterm	 infants,	at	one	month	corrected,	and	at	one	year	corrected	age.	At	birth,	compared	 to	preterm	
and	 term	 controls,	 the	 PT-RDS	 group	 had	 decreased	 right	 ventricular	 (RV)	 long-axis	 function,	 systolic	
velocity,	peak	systolic	strain,	shorter	pulmonary	arterial	acceleration	time	(PAAT)	and	lower	ratio	of	PAAT	
to	 RV	 ejection	 time	 (PAAT:RVET).	 Preterm	 infants	 had	 left	 ventricular	 (LV)	 diastolic	 dysfunction	 at	 birth	
(lower	 early	 diastolic	myocardial	 velocity,	mitral	 E	 velocity,	 and	mitral	 E:A	 ratio),	 and	 reduced	 long-axis	
systolic	velocities	and	shortening.	Differences	between	groups	disappeared	by	one	month	corrected	age,	
except	PAAT:RVET	which	remained	lower	in	the	PT-RDS	group.	At	1	year,	RV	function	was	normal	in	PT-RDS	
apart	from	systolic	strain	rate,	and	LV	function	was	normal	apart	from	lower	stroke	volume	and	shortening,	
relative	to	body	weight.	
Conclusion:	
PT-RDS	 had	 lower	 left	 and	 right	 ventricular	 systolic	 and	 diastolic	 function	 at	 birth	which	 improved	 over	
time,	suggesting	postnatal	maturation	of	cardiac	function	and	resolution	of	lung	disease.	
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INTRODUCTION	
Extremely	 preterm	 infants	with	 severe	 respiratory	distress	 syndrome	 (RDS)	 have	 evidence	of	 pulmonary	
vascular	 disease1	 and	 LV	 dysfunction.2	 In	 addition	 to	 using	 conventional	 Doppler	 echocardiographic	
parameters	such	as	tricuspid	regurgitation	(TR)	and	pulmonary	systolic	time	intervals	to	assess	pulmonary	
arterial	pressure,3-5		tissue	Doppler	imaging	(TDI)	has	been	used	to	measure	myocardial	function	in	healthy	
neonates.6-8	TDI	is	feasible	and	reproducible	in	preterm	infants9-11	and	has	been	used	to	assess	myocardial	
function	 in	 extremely	 preterm	 infants	 during	 the	 transitional	 period	 and	 serially	 until	 36	 weeks	
postmenstrual	 age.11-13	Myocardial	 function	 of	 extremely	 preterm	 infants	 has	 been	 reported	 to	 improve	
between	serial	 studies	after	birth,	 suggesting	postnatal	maturation.12,13	Myocardial	dysfunction	has	been	
detected	using	TDI	in	neonates	with	pulmonary	hypertension,	asphyxia,	and	bronchopulmonary	dysplasia	
(BPD).14-16	 Less	 is	 known	 about	 the	 effects	 of	 RDS	 on	myocardial	 function	 and	 on	 the	 natural	 history	 of	
cardiac	maturation.		
	
Vitali	 and	 colleagues	 showed	 improved	 right	 ventricular	 (RV)	 systolic	 velocity,	 tricuspid	 annular	 plane	
systolic	excursion	(TAPSE)	and	the	ratio	of	pulmonary	artery	acceleration	time	(PAAT)	to	right	ventricular	
ejection	time	(RVET)	24	hours	after	surfactant	administered	to	premature	infants	with	respiratory	distress	
syndrome.17	 James	 and	 colleagues	 reported	 that	 RV	 systolic	 tissue	 velocity,	 RV	 systolic	 strain	 rate,	 and	
TAPSE	 increased	 between	 day	 1	 and	 day	 2	 of	 life	 in	 extremely	 preterm	 infants.11	 The	 changes	 were	
attributed	to	the	decrease	in	pulmonary	vascular	resistance.	The	same	investigators	also	reported	a	lower	
RV	 strain	 in	 ventilated	 infants	 compared	 to	 infants	 on	 continuous	 positive	 airways	 pressure	 support.	 In	
contrast,	the	LV	function	of	the	extremely	preterm	infants	did	not	change	significantly	during	the	first	week	
of	life.11,12		
	
Infants	with	BPD	and/or	 pulmonary	hypertension	had	evidence	of	 abnormal	 RV	 strain	 and	RV	 fractional	
area	change18,19	but	LV	strain	was	not	affected.18		Levy	and	colleagues	also	reported	maturation	of	RV,	LV	
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and	septal	myocardial	strains	in	uncomplicated	preterm	infants	was	associated	with	increasing	weight	and	
postnatal	age.18			
	
We	undertook	 this	 prospective	observational	 study	 to	 assess	 global	 and	 regional	myocardial	 function	of	
both	ventricles	serially	in	preterm	infants	with	RDS	using	conventional	echocardiography	and	TDI	including	
strain	and	strain	rate,	and	to	compare	results	with	preterm	and	term	controls	up	to	one	year	of	age.	We	
hypothesised	that	both	global	and	regional	right	ventricular	function	are	impaired	in	preterm	infants	with	
RDS	 compared	 to	 preterm	 infants	 without	 RDS	 and	 to	 infants	 born	 at	 term,	 and	 also	 their	 ventricular	
function	would	mature	and	improve	over	the	first	year	of	life.	
	
METHODS	
Population	
120	infants	were	recruited:	60	term	infants	(≥37	weeks’	gestation)	(Term	control),	30	preterm	infants	(≤34	
weeks’	gestation)	without	RDS	(PT	Control),	and	30	preterm	infants	with	clinical	and	radiological	evidence	
of	RDS	requiring	mechanical	ventilation	at	birth	(PT-RDS).	All	groups	were	serially	assessed	until	one	year	
corrected	age.	The	study	was	approved	by	the	research	ethics	committee,	and	written	 informed	consent	
was	obtained	from	the	parents.	
	
Echocardiographic	assessment	
All	infants	were	scanned	within	72	hours	after	birth,	at	corrected	term	age	(preterm	infants),	at	one	month	
post-term,	 and	 at	 one	 year	 corrected	 age.	 Infants	 with	 congenital	 cardiac	 defects	 (other	 than	 patent	
arterial	 duct	 (PDA)	 or	 foramen	 ovale)	 were	 excluded.	 3-beat	 loops	 were	 acquired	 using	 a	 commercial	
ultrasound	 machine	 (Vivid	 7,	 GE	 Vingmed	 Ultrasound	 AS,	 Horten,	 Norway)	 with	 a	 10	 or	 7.0	 MHz	
transducer.	
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Standard	 echocardiographic	 views	 along	with	 real-time	 pulsed	 tissue	Doppler	 velocity	 profiles	 and	 color	
tissue	Doppler	loops	were	used	to	obtain	images	for	measurements	and	calculations.	LVOT	diameter,	VTI	
of	LV	outflow,	mitral	E	and	A	velocities,	TR	and	PR	velocities,	PDA	velocity,	RV	systolic	time	intervals	(PAAT,	
RVET	and	PAAT:RVET),	LVOT	area,	LV	and	RV	chamber	 lengths	at	end-diastole	(Figure	1A),	mitral	annular	
velocity	 and	 other	 tissue	 Doppler	 parameters	 were	 recorded,	 according	 to	 consensus	
recommendations.20,21	 Off-line	 analysis	 was	 performed	 using	 commercial	 software	 (EchoPAC	 7-00,	 GE	
Medical	Systems).	All	parameters	were	measured	from	3	beats	and	averaged.	Long-axis	shortening	of	the	
LV	and	RV	were	calculated	as	displacement	of	the	basal	lateral	annuli	(LV	Ds’	and	RV	Ds’)	as	a	percentage	
of	respective	diastolic	chamber	lengths.	
	
Early	 diastolic	 velocity	 (Ve’)	 was	 measured	 at	 the	 medial	 and	 lateral	 mitral	 annulus	 and	 averaged.	
Myocardial	 systolic	 velocity	 (Vs),	 early	 diastolic	 velocity	 (Ve)	 and	 velocity	 during	 atrial	 contraction	 (Va)	
were	measured	at	 the	basal	 segments	of	 the	LV	and	RV	 lateral	walls.	When	myocardial	Ve	and	Va	were	
fused	 due	 to	 rapid	 heart	 rate,	 a	 single	 diastolic	 velocity	 was	 recorded	 and	 noted	 as	 Ve.	 Annular	
displacement	in	systole	(Ds’)	was	measured	at	the	lateral	mitral	and	tricuspid	annuli	using	tissue	tracking	
(Figure	1B).	
	
Longitudinal	peak	systolic	 strain	 (Ss)	at	end-systole	was	measured	within	 the	middle	 segments	of	 the	LV	
(Figure	 2)	 and	 RV	 free	 walls,	 using	 a	 region	 of	 interest	 of	 6x3mm	 and	 a	 strain	 length	 or	 computation	
distance	of	6mm	as	we	 found	previously	 that	 that	was	most	 reproducible.10	Systolic	 (SRs),	early	diastolic	
(SRe)	and	 late	diastolic	 (SRa)	 strain	 rates	were	measured	at	 the	same	sites.	Superimposed	event	 timings	
were	derived	 from	 LVOT	and	RVOT	pulsed	Doppler	 traces.	We	have	previously	 published	our	 results	 on	
feasibility	and	reproducibility	in	preterm	infants.9		
	
Statistical	analysis	
Data	were	analyzed	using	SPSS	version	20.0	(SPSS	Inc,	Chicako,	IL,	USA).	Results	are	presented	as	mean	±	
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2SD	or	median	 (range)	as	appropriate.	Shapiro-Wilk	 test	ascertained	normality,	and	non-parametric	data	
were	compared	using	Mann-Whitney	U-test.	One-way	analysis	of	variance	(ANOVA)	with	Tukey	HSD	post-
hoc	multiple	comparisons	was	used	to	compare	the	three	groups	at	individual	time-points.	Since	the	term	
and	 preterm	 groups	 had	 three	 or	 four	 echocardiographic	 assessments	 respectively,	 repeated	measures	
ANOVA	 was	 inappropriate.	 Chi-square	 tests	 (or	 Fisher	 exact	 tests	 as	 appropriate)	 were	 used	 to	 assess	
associations	between	categorical	variables.	P<0.05	was	considered	significant.	
	
RESULTS	
Demographics	
General	 characteristics	 are	 summarized	 in	 Tables	 1	 and	 2;	 the	 PT-RDS	 group	 had	 the	 lowest	 gestation,	
birth-weight,	 and	 systolic	 and	 diastolic	 blood	 pressures.	 There	 were	 8	 preterm	 control	 infants	 and	 11	
preterm	RDS	infants	who	did	not	have	their	term	corrected	age	assessment.	7	infants	died	in	the	preterm	
RDS	group	and	the	other	preterm	infants	who	were	lost	to	follow	up	were	either	transferred	out	to	their	
local	neonatal	units	for	follow	on	care	or	discharged	prior	to	36	weeks	corrected	age	and	were	unable	to	
return	for	the	assessment.	10	out	of	19	infants	in	PT-RDS	group,	who	were	assessed	at	term	corrected	age,	
fulfilled	the	criteria	for	BPD	as	defined	by	the	2001	National	Institute	of	Health	BPD	workshop.22 PDA	was	
detected	at	birth	in	many	infants	in	all	three	groups,	but	none	was	deemed	hemodynamically	significant	or	
received	pharmacologic	or	surgical	 treatment;	no	residual	shunts	were	detected	at	one	month	corrected	
age.	
	
Infants	 in	both	preterm	groups	were	assessed	at	a	 slightly	younger	chronological	 age	compared	 to	 term	
counterparts,	at	“term”	and	at	one	month	and	one	year	of	corrected	age.	Correspondingly,	LVOTd,	and	LV	
and	 RV	 chamber	 lengths	 were	 smaller	 in	 the	 preterm	 groups	 at	 term,	 but	 these	 differences	 had	
disappeared	by	one	month	and	at	one	year,	despite	a	lower	mean	weight	in	the	PT-RDS	group	at	one	year.	
Differences	in	blood	pressure	had	resolved	by	one	month.		
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Left	ventricular	function	
LV	measurements	are	summarized	in	Tables	3	and	4.	The	PT-RDS	group	had	the	lowest	values	at	birth	for	
stroke	 volumes,	 long-axis	 shortening,	 myocardial	 systolic	 velocities	 and	 peak	 systolic	 strain,	 but	 these	
differences	had	resolved	by	one	month	of	corrected	age.	Both	preterm	groups	had	lower	LV	early	diastolic	
myocardial	velocity,	mitral	E	velocity	and	E:A	ratio	compared	to	Term	Controls.	There	were	no	difference	in	
LV	peak	systolic	and	diastolic	strain	rates	across	all	time	points;	peak	early	diastolic	strain	rate	was	higher	
in	the	preterm	groups	but	the	difference	disappeared	when	comparisons	were	adjusted	for	differences	in	
heart	rate.	
	
Right	ventricular	function	
RV	 global	 and	 regional	 systolic	 function,	 as	 indicated	 by	 long-axis	 shortening	 and	 systolic	 velocity,	were	
lower	at	birth	and	at	 corrected	 term	age	 in	 the	PT-RDS	group	 than	 in	both	 control	 groups	 (Table	5).	RV	
systolic	strain	(RV	Ss),	pulmonary	acceleration	time	(PAAT)	and	the	PAAT:RVET	ratio	were	also	lower	in	PT-
RDS	 at	 birth	 (Table	 6).	 By	 one	month	 corrected	 age,	 there	was	 no	 difference	 in	 RV	 strain	 between	 the	
groups	but	PAAT:RVET	 ratio	was	 still	 lower	 in	PT-RDS	group.	RV	early	diastolic	 velocity	was	 lower	 in	 the	
preterm	 groups	 at	 birth	 and	 the	 differences	 resolved	 by	 one	 month	 corrected	 age.	 There	 were	 no	
differences	 in	 RV	 systolic	 and	 diastolic	 strain	 rate	 between	 groups	 at	 birth,	 at	 one	month	 and	 one	 year	
corrected	age.		
	
At	birth,	25	PT-RDS	 infants	 (83%)	had	tricuspid	regurgitation,	compared	with	12	Preterm	Controls	 (40%).	
Pulmonary	regurgitation	(PR)	was	measurable	in	only	8	infants	in	each	group	(27%).	The	velocities	recorded	
were	comparable	(TR	2.0	(0.8)	m/s	 in	PT-RDS,	2.0	(0.8)	m/s	in	Preterm	Controls,	p=0.99;	and	PR	0.6	(0.4)	
and	 0.7	 (0.4)m/s,	 p=0.78).	 No	 differences	were	 noted	 between	 the	 groups	 for	 tricuspid	 and	 pulmonary	
regurgitation	respectively	at	any	period.	
	
Maturation	of	myocardial	function	
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Parameters	for	LV	global	and	regional	systolic	and	diastolic	function	were	lower	in	preterm	groups	at	birth	
than	 in	 term	 controls,	 apart	 from	 LV	 systolic	 and	 diastolic	 strain	 rates	 (Tables	 2-4).	 These	 differences	
disappeared	by	 term	corrected	age	but	stroke	volume	remained	 lower	 in	preterm	groups	whereas	heart	
rate,	 long-axis	 shortening	 and	 cardiac	 output	were	 higher.	 At	 one	 year,	 PT-RDS	 group	 had	 lower	 stroke	
volume	(by	12%,	p<0.05)	and	LV	long-axis	shortening	(by	9%,	p<0.025)	than	control	groups	despite	having	
comparable	ventricular	size.	All	markers	of	LV	regional	myocardial	function	matured	over	the	first	year.	
	
A	similar	pattern	was	observed	for	RV	global	and	regional	function	where	differences	disappeared	at	one	
month	and	at	one	year	corrected	age	(Tables	4-5).		
	
DISCUSSION	
In	this	study,	we	used	conventional	echocardiography	and	myocardial	velocity	and	deformation	imaging	(or	
tissue	Doppler	imaging,	TDI)	to	assess	global	and	regional	myocardial	function	of	both	ventricles	in	preterm	
infants	 with	 RDS,	 and	 compared	 the	 results	 with	 preterm	 and	 term	 control	 infants	 during	 serial	
examinations	recorded	up	to	one	year	of	age.	Our	main	findings	are	that	PT-RDS	infants	had	lower	LV	and	
RV	systolic	 function	at	birth	 that	 improved	over	 time	such	 that	 there	were	no	measurable	difference	by	
one	month	corrected	age,	and	that	their	cardiac	function	continued	to	mature	during	the	first	year	of	life.	
We	used	TDI-derived	strain	and	strain	rate	to	assess	regional	ventricular	function	in	the	extremely	preterm	
infants,	rather	than	speckle	tracking,	because	of	their	much	higher	temporal	resolution	which	is	necessary	
for	 studying	 function	 at	 fast	 heart	 rates.23	 Overall,	 the	 detailed	 echocardiographic	 parameters	 were	
obtained	in	more	than	95%	of	the	studies.			
	
LV	function	and	maturation	in	the	first	year	of	life	
Other	 investigators	have	also	 reported	a	progressive	 increase	 in	 LV	systolic	 function24,25	but	 in	our	 study	
the	changes	cannot	be	explained	solely	by	differences	in	body	weight,	because	long-axis	shortening	of	the	
LV	remained	lower	in	PT-
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mechanical	 ventilation	and	20%	 required	 inotropic	 support	with	a	 low-dose	dopamine	 infusion.	Preterm	
myocardium,	which	lacks	sarcoplasmic	reticulum,	relies	mainly	on	the	L-type	calcium	channels	to	trigger	a	
weaker	 muscle	 contraction	 compared	 to	 the	 more	 mature	 infants.26	 Additionally,	 the	 immature	
myocardium	 contains	 a	 higher	 proportion	 of	 non-contractile	 collagen,	 which	 impairs	 relaxation	 and	
ventricular	filling	during	diastole.27	Breatnach	and	colleagues	reported	that	infants	who	received	inotropes	
had	 lower	LV	and	septal	early	myocardial	 velocities	whereas	a	hemodynamically	 significant	PDA	 (hsPDA)	
had	the	reverse	effect	on	the	same	parameters.13	In	our	study,	the	comorbidities	associated	with	extreme	
prematurity	may	have	contributed	to	the	myocardial	dysfunction.			
		
The	mitral	 E:A	 ratio	was	 lower	 in	 our	 preterm	 groups	 than	 in	 the	 Term	 Controls;	 a	 similar	 pattern	was	
observed	for	fetal	cardiac	function.28,29	When	assessed	at	term,	the	mitral	E:A	ratio	normalized	and	became	
comparable	 to	 term	 infants.	 Two	 other	 groups	 also	 reported	 that	 the	 mitral	 E	 velocity	 continued	 to	
increase	up	to	one	year30,31	implying	that	ventricular	diastolic	function	continues	to	evolve	during	infancy.		
The	E/e’	ratio	is	a	non-invasive	correlate	of	mean	LV	filling	pressure	in	adults	that	to	our	knowledge	has	not	
been	validated	against	 invasive	measurements	 in	 infants.	 It	was	similar	 in	all	groups	at	birth,	which	may	
suggest	that	LV	preload	was	normal	despite	the	lung	disease	in	the	PT-RDS	group.	Left	ventricular	filling	in	
preterm	infants	was	more	dependent	on	atrial	systole.	
	
Similar	changes	were	seen	in	the	LV	lateral	wall	systolic	velocity	and	strain	which	increased	over	time	in	the	
PT-RDS	 group	where	 the	 differences	 between	 the	 groups	 disappear	 by	 one	month	 corrected	 age.	 Fetal	
studies	have	shown	the	LV	lateral	wall	velocities	increases	from	mid-trimester	to	term29,32	and	Klitsie	and	
colleagues	 reported	that	LV	systolic	and	diastolic	 function	 increased	up	to	7	weeks	after	birth	 in	healthy	
term	infants.33	These	studies	suggest	that	LV	systolic	 function	and	relaxation	 improve	with	fetal	maturity	
and	continue	to	improve	postnatally.		
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LV	myocardial	strain	was	lowest	in	the	PT-RDS	group	at	birth	with	no	measurable	reduction	in	preload	or	
evidence	of	increased	afterload	as	their	blood	pressure	was	lower	than	the	control	groups.	This	suggests	an	
inherent	reduction	in	LV	systolic	function	as	a	result	of	prematurity.	LV	peak	systolic	strain	of	PT-RDS	group	
increased	and	became	similar	to	the	control	groups	by	one	month	of	corrected	age.	Our	finding	is	slightly	
different	from	those	published	by	other	groups	where	LV	strain	had	remained	stable	from	birth	through	to	
28	days	 and	 36	weeks	post-menstrual	 age.12,34	 Levy	 and	 colleagues	 used	 2D	 speckle	 tracking	method	 to	
assess	LV	global	strain	reported	an	initial	increase	in	LV	strain	in	the	first	7	days	of	life	but	thereafter	the	LV	
strain	value	stabilized	until	1	year	corrected	age.18	One	possible	reason	for	this	discrepancy	between	our	
finding	 and	 other	 published	 data	 could	 be	 to	 the	 timing	 of	 the	 assessments.	 Our	 study	 assessed	 these	
infants	within	the	first	72	hours	of	life	and	the	second	follow	assessment	occurred	at	term	corrected	age.	
Another	 possible	 explanation	 could	 be	 underestimation	 of	 the	 LV	 strain	 in	 the	 smallest	 hearts	with	 our	
tissue	Doppler	technique	and	the	difficulty	in	maintaining	a	small	insonation	angle.	However,	the	LV	strain	
of	23±4%	in	the	larger	Term	Controls	at	birth	in	our	study	is	comparable	to	other	reports.6,7,35	The	increases	
in	 LV	 strain	 in	 all	 groups	were	 not	 as	 high	 as	 those	 seen	 in	 the	 RV	 and	 this	 is	 due	 to	 the	 difference	 in	
myocardial	 fiber	 architecture	 between	 LV	 and	 RV.36,37	 Levy	 and	 colleagues	 reported	 infants	 with	 hsPDA	
have	higher	LV	global	strain	but	no	difference	in	LV,	RV,	and	septal	wall	strains	in	infants	with	PDA	that	did	
not	require	treatment	compared	to	those	without	PDA.	18	Strain	rate	was	similar	in	all	groups	at	every	time	
interval,	 implying	that	the	preterm	infants	had	normal	 intrinsic	contractile	function	across	all	 time	points	
and		is	not	affected	by	cardiac	growth.33,38	
	
Pulmonary	artery	pressure	assessment,	right	ventricular	function	and	its	maturation	in	the	first	year	of	
life	
We	did	not	detect	any	difference	in	pulmonary	arterial	pressure	based	on	TR	jet	findings	between	PT-RDS	
and	the	control	groups	at	birth.	TR	 jet	can	be	difficult	to	be	detected	and	was	only	detected	 in	 less	than	
50%	 of	 infants	 with	 CLD	 and	 pulmonary	 hypertension	 in	 one	 study.5	 Even	 if	 this	 is	 detected,	 TR	 jet	
correlates	 poorly	with	 the	 pulmonary	 arterial	 pressure	measured	 by	 right	 heart	 catheterization	 (RHC).39	
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The	TR	measurements	 in	PT-RDS	 infants	were	most	 likely	under-estimated	 in	our	 study	as	PAAT:RVET	 in	
the	same	group	was	significantly	lower	(0.27)	than	controls	(0.31)	,	implying	they	had	increased	pulmonary	
arterial	pressures.4,40,41	PAAT:RVET	<0.31	has	been	validated	against	RHC	to	have	97%	sensitivity	and	95%	
specificity	at	detecting	pulmonary	hypertension	in	children.4	These	time	intervals	could	be	measured	in	all	
infants,	 unlike	 tricuspid	 regurgitation	which	was	 detectable	 in	 approximately	 two	 thirds	 of	 the	 preterm	
infants	in	our	study.	
	
Vitali	and	colleagues	assessed	 the	changes	 in	PAAT:RVET,	myocardial	velocities,	 right	and	 left	ventricular	
output	and	TAPSE	at	2	and	24	hours	post	surfactant	administration	 in	a	small	cohort	of	preterm	 infants.	
They	found	an	improvement	in	all	the	parameters	measured	following	surfactant	administration	but	only	
after	 24	 hours	 post	 surfactant	 administration.17	 Our	 PT-RDS	 infants	 had	 significantly	 low	 systolic	
displacement	 of	 the	 tricuspid	 annulus	 (RV	 Ds’)	 and	 RV	 long	 axis	 shortening,	 both	markers	 of	 RV	 global	
systolic	function,	at	birth.	A	similar	reduction	in	regional	function	represented	by	RV	systolic	velocity	and	
strain,	and	 late	diastolic	velocity	were	also	noted	at	birth	 in	the	background	of	raised	pulmonary	arterial	
pressure	 in	 the	PT-RDS	group	compared	to	the	two	control	groups.	These	parameters	 improved	by	term	
corrected	 age	 compared	 to	 preterm	 controls	 implying	 improvement	 of	 RV	 function	 despite	 evidence	 of	
increased	pulmonary	arterial	pressure.	PAAT:RVET	in	the	PT-RDS	group	remained	significantly	lower	at	the	
term	corrected	age	and	persisted	until	one	month	corrected	age.	10	infants	from	PT-RDS	group	fulfilled	the	
BPD	 criteria	 and	 it	 is	 possible	 that	 the	 pulmonary	 pressures	 remained	 elevated.	We	 did	 not	 detect	 any	
residual	RV	systolic	dysfunction	in	our	PT-RDS	group	after	term	corrected	age.	Helfer	and	colleagues	found	
that	infants	who	developed	BPD	had	significantly	lower	RV	free	wall	longitudinal	strain	on	days	14	and	28	
of	 life34.	 Levy	 and	 colleagues	 found	 in	 their	 study,	 infants	 with	 BPD	 and	 pulmonary	 hypertension	 have	
persistent	RV	dysfunction	on	2D	speckle	 tracking	derived	strain	measurements	up	 to	one	year	corrected	
age	despite	being	 clinically	 free	 from	 lung	disease	and	oxygen	dependency.18	 This	potentially	 could	help	
identify	infants	who	are	at	higher	risk	of	developing	BPD.	In	both	these	studies,	the	RV	longitudinal	strain	
increased	with	age	but	the	rate	of	 increase	is	slower	 in	BPD	infants.	Levy	and	colleagues	also	report	that	
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10%	of	 infants	without	BPD	had	detectable	pulmonary	hypertension	at	36	weeks	corrected	age	also	had	
decreased	 RV	 longitudinal	 strain.18	 This	 suggests	 a	 primary	 vascular	 injury	 that	 may	 occur	 in	 some	
extremely	 preterm	 infants,	 independent	 of	 lung	 disease.	We	 reported	 that	 children	 aged	 8-12	who	 had	
BPD	 had	 normal	 myocardial	 function	 and	 responses	 to	 hypoxia42	 but	 had	 increased	 pulmonary	 arterial	
stiffness	during	hypoxia.43	Children	who	had	BPD	have	increased	pulmonary	vascular	reactivity	to	hypoxia	
thus	may	be	at	risk	of	developing	pulmonary	hypertension	at	an	earlier	age	compared	to	healthy	preterm	
infants	despite	normal	cardiovascular	function	at	rest	during	normoxia.	
	
The	 preterm	 groups	 showed	 postnatal	 adaptation	 during	 their	 neonatal	 period	 and	 a	 significant	
improvement	 in	their	RV	systolic	 function	(RV	Ds’,	RV	 long	axis	shortening,	RV	 longitudinal	systolic	strain	
and	 RV	 systolic	 strain	 rate)	 and	 RV	 diastolic	 function	 (RV	 Vebl	 and	 RV	 Vabl)	 at	 term	 corrected	 age	
compared	to	the	term	controls	at	birth.	This	progressive	 increase	 in	RV	systolic	 function	could	be	due	to	
the	fall	in	the	pulmonary	vascular	resistance	and	also	suggest	an	increase	in	RV	contractile	function	in	the	
postnatal	period.	It	is	reassuring	to	note	that	both	RV	systolic	and	diastolic	function	of	the	preterm	infants	
continue	develop	 in	 line	with	 the	term	 infants	when	assessed	at	one	month	and	one	year	corrected	age	
respectively.	 This	 observation	 was	 also	 noted	 by	 other	 investigators	 who	 used	 speckle	 tracking	
echocardiography	to	assess	ventricular	functions	of	the	preterm	infants.2,18		
	
Clinical	application	of	the	study	
Our	 study	 adds	 TDI	 myocardial	 velocities	 and	 TDI-derived	 strain	 and	 strain	 rate	 data	 to	 the	 growing	
literature	in	this	population.	We	have	successfully	used	tissue	Doppler	echocardiography	and	TDI-derived	
strain	and	strain	rate	to	assess	the	both	regional	and	global	ventricular	function	in	the	preterm	population.	
TDI-derived	strain	measurement	of	the	RV	can	be	used	to	monitor	longitudinally	cardiopulmonary	disease	
in	the	first	year	especially	in	infants	with	moderate	and	severe	BPD	where	conventional	echocardiographic	
parameters	may	not	be	sensitive	to	detect.	In	cases	where	TR	jet	is	absent	or	the	envelope	is	incomplete,	
PAAT:RVET	 is	 a	 good	 surrogate	 marker	 for	 pulmonary	 artery	 pressure	 or	 compliance.	 LV	 myocardial	
Kotecha	13	
	
velocities	 at	 the	 lateral	 mitral	 annulus	 were	 sensitive	 and	 easily	 reproducible	 measurements	 for	 serial	
follow-up	of	LV	systolic	and	diastolic	function	in	preterm	infants.	Additionally,	we	have	also	shown	in	our	
previous	study	that	LV	lateral	wall	mid-segment	longitudinal	peak	systolic	strain,	mitral	E,	mitral	A,	and	E:A	
ratio	were	highly	reproducible.9,10			
	
Limitations	
We	 started	 the	 study	with	 120	 infants	 in	 three	 groups	 but	 follow-up	 rates	 at	 one	month	 and	 one	 year	
represented	64%	and	55%	of	 the	120	 subjects.	We	performed	analysis	 comparing	 infants	who	attended	
follow	ups	at	one	month	or	one	year	corrected	age	and	those	who	dropped	out	and	found	no	difference	in	
baseline	 characteristics	 or	 in	 the	 parameters	 of	 cardiac	 function	 at	 the	 first	 assessment	 (Supplementary	
table	1).	We	are	 satisfied	 that	 those	 followed	up	were	 representative	of	 the	group.	A	 subgroup	analysis	
comparing	BPD	 infants	 and	non-BPD	 infants	within	 the	RDS	group	at	 term	corrected	age	only	 showed	a	
difference	 in	 RV	 longitudinal	 axis	 shortening	 (p=0.037)	 in	 a	 small	 cohort	 that	 is	 insufficiently	 powered	
(Supplementary	table	2).	Even	though	the	2:1:1	ratio	between	groups	was	preserved,	the	relatively	small	
sample	size	at	one	month	and	one	year	assessments	may	not	be	sufficiently	powered	to	detect	differences	
between	the	groups.	However,	our	findings	are	comparable	to	other	published	studies	as	discussed	above.		
	
We	used	TDI-derived	 strain	 to	 assess	 LV	 and	RV	 free	wall	 function.	 TDI-derived	 strain	 is	 able	 to	 capture	
images	at	higher	temporal	resolution	compared	to	2D	speckle	tracking	in	the	assessment	of	strain	 in	this	
population	 consisting	 extremely	 preterm	 infants	 who	 have	 high	 heart	 rate.	 We	 decided	 to	 place	 the	
sampling	 area	 in	 the	 middle	 segment	 to	 avoid	 adjacent	 structures	 affecting	 the	 measurements	 as	 the	
ventricular	size	of	the	PT-RDS	group	is	approximately	18mm.6	By	placing	the	sampling	area	in	the	middle	
segment	of	the	LV	free	wall,	in	the	smallest	preterm	infants,	this	actually	sampled	almost	the	whole	of	the	
free	wall.	It	has	been	suggested	that	measuring	strain	in	the	middle	segment	more	reliable	for	serial	follow	
ups	 in	 this	population.6	We	have	reported	good	reproducibility	measuring	LV	strain	at	 this	site	using	our	
sampling	size	and	strain	length.10	We	are	aware	of	the	limitations	associated	with	TDI	and	tried	to	minimize	
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the	 deviation	 between	 the	 wall	 segment	 and	 ultrasonic	 beam	 to	 below	 20⁰.	 Assessment	 of	myocardial	
function	in	the	fetus	and	neonate	using	2D	speckle	tracking44,45	is	both	feasible	and	more	reproducible,	in	
addition	to	allowing	the	assessments	of	both	regional	and	global	strain.	However,	2D	speckle	tracking	may	
have	disadvantages	due	to	smoothing	and	limited	temporal	resolution.	In	our	study,	signal	noise	are	likely	
to	 have	 affected	 strain	 rate	 measurements,	 which	 could	 explain	 why	 they	 were	 less	 sensitive	 for	
demonstrating	subtle	differences	between	groups,	especially	in	the	LV	free	wall.		
	
	
CONCLUSION	
Preterm	 infants	 with	 RDS	 have	 lower	 left	 and	 right	 ventricular	 systolic	 and	 diastolic	 function	 at	 birth	
compare	 to	 the	 larger	preterm	and	 term	control	 groups.	 These	 improve	with	 time,	 suggesting	postnatal	
maturation	of	cardiac	function	and	resolution	of	their	lung	disease.		 	
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Table	1:	Maternal	and	infant	characteristics		
	
	
Term	Control	
(A)	
PT	Control	
(B)	
PT	RDS		
(C)	
p-value	
	
	 	 	 	 	
	 	 	 	 	
Number	 60	 30	 30	 	
Male	:	Female	(n)	 31:29	 18:12	 21:9	 -	
Gestation	(weeks)	 39.8	(1.2)	 32.7	(1.4)	 28.2	(2.7)	 <0.001§,	§§,	§§§	
Birth	weight	(kg)	 3.4	(0.5)	 1.8	(0.4)	 1.2	(0.4)	 <0.001§,	§§,	§§§	
	
Antenatal	corticosteroids	(n)	 -	 26	(87%)	 22	(73%)	 0.197	
Multiple	births	(n,	%)	 2	(3%)	 10	(33%)	 5	(17%)	 0.001	
Caesarean	section	(n,	%)	 10	(17%)	 16	(53%)	 9	(30%)	 0.001	
Maternal	smoking	(n,	%)	 11	(18%)	 12	(40%)	 11	(37%)	 0.05	
Maternal	fever	(n,	%)	 2	(3%)	 3	(10%)	 1	(3%)	 0.349	
Prolonged	rupture	of	membranes	(n,	%)	 3	(5%)	 10	(33%)	 6	(20%)	 0.002	
	 	 	 	 	
Inotropic	support	(n,	%))	 -	 -	 6	(20%)	 -	
Patent	ductus	arteriosus	(n,	%)	 27	(45%)	 7	(23%)	 19	(63%)	 0.008	
	 	 	 	 	
Ventilation	/	respiratory	parameters	 	 	
Surfactant	therapy	(n,	%)	 -	 -	 30	(100%)	 	
Conventional	ventilation:HFOV	(n)	 -	 -	 26:4	 	
Highest	peak	pressure	(cmH20)	 -	 -	 21.8	(3.9)	 -	
Duration	of	ventilation	(days)	 -	 -	 14.0	(17.5)	 -	
Duration	of	O2	dependency	(days	 -	 4.4	(7.9)		 57.9	(83.6)	 <0.001	
Postnatal	steroids	(n,	%)	 -	 -	 0	(%)	 	
Bronchopulmonary	dysplasia*	(n,	%)	 -	 -	 10	(33%)	 -	
	 	 	 	 	
Necrotising	enterocolitis	(n,	%)	 -	 -	 4	(13%)	 -	
ROP	threshold	(Stage	2	plus	or	above)	(n,	%)	 -	 -	 4	(13%)	 -	
IVH	(grade	3	or	4)	 -	 -	 3	(10%)	 -	
	 	 	 	 	
HFOV,	high	frequency	oscillation	ventilation;	ROP,	retinopathy	of	prematurity;	IVH,	intraventricular	hemorrhage.	
Results	are	presented	as	mean	(SD)	or	as	number	(percentage).		
§	p	<0.001	(PT	RDS	V	PT	control),	§§	p	<0.001	(PT	RDS	V	Term	control),	§§§	p	<0.001	(PT	control	V	Term	control),	†	p	
<0.05	(PT	RDS	V	PT	control)	
*Bronchopulmonary	dysplasia	as	defined	by	2001	National	Institute	of	Health	BPD	workshop19	
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Table	2:	General	characteristics,	blood	pressure,	and	ventricular	sizes	
	 Term	Control		 PT	Control		 PT-RDS		 p-value	
Numbers	
Birth	 60	 30	 30	 -	
At	term	 60	 22	 19	 -	
1	month	 45	 17	 15	 -	
1	year	 33	 18	 16	 -	
Age	(weeks)	 	 	 	 	
Birth	 39.8(1.2)	 32.7(1.4)	 28.2(2.7)	 <0.001§,§§,§§§	
At	term	 "	 37.3(1.9)	 36.7(1.4)	 <0.001§§,§§§	
1	month	 5.3(1.0)	 4.6(1.8)	 3.8(1.6)	 0.002‡‡	
1	year	 53.0(2.3)	 51.9(3.5)	 49.2(4.2)	 0.001§§,§§§	
Weight	(kg)	 	 	 	 	
Birth	 3.4(0.5)	 1.8(0.4)	 1.2(0.4)	 <0.001§,§§,§§§	
At	term	 "	 2.5(0.7)	 2.3(0.4)	 <0.001§§,§§§	
1	month	 4.5(0.6)	 4.3(0.8)	 4.1(0.5)	 0.064	
1	year	 9.8(1.1)	 9.5(1.2)	 8.8(1.4)	 0.041††	
ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Systolic	BP	(mmHg)	 	 	 	 	
Birth	 66.9(11.7)	 65.1(10.8)	 49.3(7.8)	 <0.001§,§§	
At	term	 "	 65.8(10.1)	 49.1(6.7)	 <0.001§,§§	
1	month	 95.6(14.0)	 95.3(14.5)	 99.1(20.7)	 0.765	
1	year	 106.3(21.2)	 107.8(18.7)	 92.2(14.1)	 0.058	
ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Diastolic	BP	(mmHg)	 	 	 	 	
Birth	 41.3(9.9)	 37.1(7.8)	 30.8(7.5)	 <0.001†,§§	
At	term	 "	 37.2(8.3)	 29.1(6.0)	 <0.001†,§§	
1	month	 60.7(11.0)	 57.7(13.4)	 58.6(13.3)	 0.688	
1	year	 70.1(14.4)	 71.5(13.3)	 61.5(10.9)	 0.095	
ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Heart	rate	(bpm)	 	 	 	 	
Birth	 115(19)	 136(15)	 143(16)	 <0.001§§,§§§	
At	term	 "	 159(16)	 155(12)	 <0.001§§,§§§	
1	month	 152(17)	 160(21)	 153(14)	 0.276	
1	year	 125(15)	 131(20)	 127(17)	 0.473	
ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
End-diastolic	left	ventricular	chamber	lengths	(cm)	
Birth	 2.8(0.3)	 2.1(0.2)	 1.8(0.3)	 <0.001§,§§,§§§	
At	term	 "	 2.5(0.4)	 2.6(0.4)	 <0.01††,‡‡‡	
1	month	 3.1(0.2)	 3.1(0.2)	 3.0(0.2)	 0.263	
1	year	 4.0(0.2)	 3.9(0.3)	 3.9(0.2)	 0.340	
ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
End-diastolic	right	ventricular	chamber	lengths	(cm)	
Birth	 2.6(0.3)	 2.0(0.2)	 1.8(0.3)	 <0.001§,§§,§§§	
At	term	 "	 2.3(0.4)	 2.4(0.3)	 <0.001‡‡,‡‡‡	
1	month	 3.0(0.2)	 3.1(0.3)	 2.9(0.2)	 0.420	
1	year	 3.9(0.2)	 3.9(0.3)	 3.8(0.2)	 0.636	
ANOVA	(p	value)		 <0.001	 <0.001	 <0.001	 	
	 	 	 	 	
Results	are	presented	as	mean(SD).	
§p	<0.001(PT-RDS	v	PTC),	§§p	<0.001(PT-RDS	v	TC),	§§§p	<0.001(PTC	v	TC),		
‡p	<0.01(PT-RDS	v	PTC),	‡‡p	<0.01(PT-RDS	v	TC),	‡‡‡p	<0.01(PTC	v	TC),		
†p	<0.05(PT-RDS	v	PTC),	††p	<0.05(PT-RDS	v	TC),	†††p	<0.05(PTC	v	TC)	
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Table	3:	Left	ventricular	global	systolic	and	diastolic	function	
	 Term	Control		 PT	Control		 PT-RDS		
ANOVA	
p-value	
LVOT_d	(cm)	 	 	 	 	
						Birth	 0.66(0.07)	 0.53(0.06)	 0.45(0.08)	 <0.001§,§§,§§§	
						At	term	 "	 0.62(0.06)	 0.58(0.06)	 <0.001§§	
						1	month	 0.77(0.07)	 0.75(0.06)	 0.73(0.07)	 0.109	
						1	year	 0.98(0.07)	 0.96(0.07)	 0.92(0.08)	 0.097	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
LVOT	VTI	(cm)	 	 	 	 	
						Birth	 12.5(2.4)	 10.2(2.3)	 8.6(2.5)	 <0.001†,§§,§§§	
						At	term	 "	 12.7(2.9)	 13.2(2.0)	 0.583	
						1	month	 13.9(2.2)	 15.0(2.0)	 14.5(1.6)	 0.206	
						1	year	 17.2(1.7)	 16.9(2.0)	 16.8(2.8)	 0.870	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Stroke	volume	(ml)	 	 	 	 	
						Birth	 4.3(1.2)	 2.3(0.8)	 1.4(0.6)	 <0.001‡,§§,§§§	
						At	term	 "	 2.5(0.7)	 2.3(0.4)	 0.014††	
						1	month	 6.5(1.5)	 6.7(1.3)	 6.0(1.0)	 0.314	
						1	year	 12.8(1.6)	 12.1(1.8)	 11.3(2.3)	 0.043††	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Cardiac	output	(ml/min)	 	 	 	 	
						Birth	 489(125)	 305(114)	 194(83)	 <0.001‡,§§,§§§	
						At	term	 "	 624(204)	 541(142)	 0.002‡‡‡	
						1	month	 989(248)	 1070(247)	 909(151)	 0.151	
						1	year	 1600(290)	 1590(262)	 1420(221)	 0.081	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
LV	Ds’	(mm)	 	 	 	 	
						Birth	 4.6(1.0)	 3.4(0.8)	 2.6(1.0)	 <0.001‡,§§,§§§	
						At	term	 "	 5.8(1.3)	 5.0(1.1)	 <0.001†,§§§	
						1	month	 7.5(1.2)	 7.2(0.8)	 6.6(0.9)	 0.037††	
						1	year	 9.5(1.2)	 8.7(1.1)	 8.5(1.0)	 0.007††,†††	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
LVbl	long	axis	shortening	(%)	
						Birth	 16.3(3.6)	 15.7(3.5)	 14.0(5.1)	 0.047††	
						At	term	 "	 22.6(3.0)	 18.8(3.1)	 <0.001‡,††,§§§	
						1	month	 23.7(3.8)	 23.0(2.6)	 21.9(2.6)	 0.200	
						1	year	 24.0(3.0)	 22.2(2.3)	 21.9(2.3)	 0.022††	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Mitral	E	(m/s)	 	 	 	 	
						Birth	 0.64(0.12)	 0.52(0.11)	 0.47(0.14)	 <0.001§§,§§§	
						At	term	 "	 0.96(0.24)	 0.94(0.20)	 <0.001§§,§§§	
						1	month	 1.04(0.21)	 1.08(0.18)	 1.09(0.16)	 0.649	
						1	year	 1.18(0.15)	 1.16(0.19)	 1.11(0.09)	 0.271	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Mitral	A	(m/s)	 	 	 	 	
						Birth	 0.57(0.11)	 0.56(0.11)	 0.52(0.13)	 0.081	
						At	term	 "	 0.92(0.22)	 0.91(0.15)	 <0.001§§,§§§	
						1	month	 0.90(0.20)	 1.00(0.22)	 0.94(0.14)	 0.270	
						1	year	 0.88(0.16)	 0.92(0.18)	 0.79(0.19)	 0.106	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
Mitral	E:A	 	 	 	 	
						Birth	 1.13(0.23)	 0.95(0.18)	 0.92(0.22)	 <0.001§§,§§§	
						At	term	 "	 1.03(0.13)	 1.02(0.21)	 0.054	
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						1	month	 1.14(0.18)	 1.06(0.18)	 1.10(0.17)	 0.293	
						1	year	 1.36(0.22)	 1.23(0.21)	 1.44(0.22)	 0.030†	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
LVOT_d,	left	ventricular	outflow	tract	diameter;	LVOT_VTI,	left	ventricular	outflow	tract	velocity-time	integral;	LV	Ds’,	
left	ventricular	lateral	annular	displacement;	LVbl,	left	ventricular	basal	lateral.	
Results	are	presented	as	mean(SD)	
§p	<0.001(PT-RDS	v	PTC),	§§p	<0.001(PT-RDS	v	TC),	§§§p	<0.001(PTC	v	TC),		
‡p	<0.01(PT-RDS	v	PTC),	‡‡p	<0.01(PT-RDS	v	TC),	‡‡‡p	<0.01(PTC	v	TC),		
†p	<0.05(PT-RDS	v	PTC),	††p	<0.05(PT-RDS	v	TC),	†††p	<0.05(PTC	v	TC)	
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Table	4:	Left	ventricular	regional	myocardial	function	(lateral	wall)	
	
LV	 Vsbl,	 left	 ventricular	myocardial	 systolic	 velocity	 at	 basal	 lateral	wall;	 LV	 Vebl,	 left	 ventricular	myocardial	 early	
diastolic	velocity	at	basal	lateral	wall;	LV	Vabl,	left	ventricular	myocardial	late	diastolic	velocity	at	basal	lateral	wall;	LV	
Ssl,	left	ventricular	longitudinal	peak	systolic	strain;	LV	SRs,	left	ventricular	systolic	strain	rate;	LV	SRe,	left	ventricular	
early	diastolic	strain	rate;	LV	SRa,	left	ventricular	late	diastolic	strain	rate.	
Results	are	presented	as	mean(SD)	 	
§p	<0.001(PT-RDS	v	PTC),	§§p	<0.001(PT-RDS	v	TC),	§§§p	<0.001(PTC	v	TC),		
‡p	<0.01(PT-RDS	v	PTC),	‡‡p	<0.01(PT-RDS	v	TC),	‡‡‡p	<0.01(PTC	v	TC),		
†p	<0.05(PT-RDS	v	PTC),	††p	<0.05(PT-RDS	v	TC),	†††p	<0.05(PTC	v	TC)	 	
	
	
Term	Control	 PT	Control	 PT-RDS	
ANOVA	
p-value	
LV	Vsbl	(cm/s)	 	 	 	 	
						Birth	 3.0(0.8)	 2.1(0.7)	 1.7(0.8)	 <0.001§§,§§§	
						At	term	 "	 3.4(0.8)	 3.1(1.0)	 0.121	
						1	month	 4.3(0.9)	 4.3(1.2)	 3.9(1.1)	 0.481	
						1	year	 4.8(1.0)	 4.7(1.0)	 4.7(0.7)	 0.861	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
LV	Vebl	(cm/s)	 	 	 	 	
						Birth	 4.5(1.1)	 3.5(1.1)	 2.5(1.2)	 <0.001‡,§§,§§§	
						At	term	 "	 6.8(1.5)	 5.9(1.9)	 <0.001§§,§§§	
						1	month	 9.1(2.4)	 8.3(2.6)	 8.2(2.5)	 0.292	
						1	year	 11.7(2.1)	 11.0(1.9)	 10.8(1.2)	 0.190	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
LV	Vabl	(cm/s)	 	 	 	 	
						Birth	 3.7(1.4)	 3.1(1.1)	 2.8(1.2)	 0.003‡‡	
						At	term	 "	 4.9(1.0)	 4.2(0.9)	 0.015†††	
						1	month	 5.2(1.1)	 4.8(1.2)	 4.0(1.9)	 0.178	
						1	year	 3.7(1.6)	 3.6(1.0)	 3.4(0.8)	 0.850	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
LV	lateral	wall	mid-segment	longitudinal	peak	systolic	strain,	Ssl	(%)	
						Birth	 -22.8(3.9)	 -21.2(3.8)	 -18.9(4.9)	 <0.001§§	
						At	term	 "	 -25.5(5.1)	 -22.8(4.7)	 0.041†††	
						1	month	 -27.7(5.3)	 -27.2(3.1)	 -27.5(4.7)	 0.928	
						1	year	 -31.7(4.0)	 -31.0(3.6)	 -29.1(3.2)	 0.079	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
LV	SRsl	(/s)	 	 	 	 	
						Birth	 -2.2(0.8)	 -1.9(0.5)	 -2.0(0.8)	 0.116	
						At	term	 "	 -2.4(0.7)	 -2.3(0.9)	 0.758	
						1	month	 -2.5(1.1)	 -2.9(0.6)	 -2.4(1.0)	 0.370	
						1	year	 -3.4(1.2)	 -3.1(1.0)	 -3.3(1.1)	 0.627	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
LV	SRel	(/s)	 	 	 	 	
						Birth	 2.7(0.9)	 3.1(0.9)	 2.6(0.9)	 0.172	
						At	term	 "	 4.5(1.4)	 3.8(1.3)	 <0.001§§,§§§	
						1	month	 5.0(1.3)	 4.6(1.2)	 5.4(1.2)	 0.178	
						1	year	 6.0(1.5)	 5.6(1.1)	 5.1(0.7)	 0.068	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
LV	SRal	(/s)	 	 	 	 	
						Birth	 2.4(1.0)	 2.5(0.8)	 2.8(0.9)	 0.188	
						At	term	 "	 3.0(0.8)	 2.9(1.1)	 0.123	
						1	month	 3.5(1.2)	 3.1(1.4)	 2.9(1.3)	 0.394	
						1	year	 2.7(1.1)	 2.3(0.7)	 2.1(0.7)	 0.135	
						ANOVA	(p-value)	 <0.01	 0.121	 0.104	 	
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Table	5:	Right	ventricular	global	and	regional	(free	wall)	myocardial	function	
	
	 Term	Control	 PT	Control	 PT-RDS	
ANOVA	
p-value	
RV	Ds’	(mm)	 	 	 	 	
						Birth	 7.6(1.3)	 5.9(1.1)	 4.4(1.3)	 <0.001§,§§,§§§	
						At	term	 "	 8.4(1.7)	 8.4(1.2)	 0.030	
						1	month	 9.6(1.4)	 10.4(1.7)	 10.2(1.3)	 0.119	
						1	year	 14.4(1.8)	 14.6(2.0)	 13.4(2.0)	 0.113	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
RV	long	axis	shortening	(%)	 	 	 	 	
						Birth	 28.7(4.5)	 29.2(4.4)	 25.1(6.6)	 0.003‡,‡‡	
						At	term	 "	 35.6(4.3)	 35.7(6.8)	 <0.001§§,§§§	
						1	month	 31.9(4.3)	 34.1(3.6)	 34.6(3.8)	 0.037	
						1	year	 37.0(4.9)	 37.6(3.6)	 34.8(4.6)	 0.169	
						ANOVA	(p-value)		 <0.001	 <0.001	 <0.001	 	
RV	Vsbl	(cm/s)	 	 	 	 	
						Birth	 4.3(0.9)	 3.7(0.8)	 2.7(0.8)	 <0.001§,§§,‡‡‡	
						At	term	 "	 4.9(1.5)	 4.7(1.1)	 0.059	
						1	month	 5.4(1.3)	 6.0(1.1)	 5.8(1.1)	 0.283	
						1	year	 7.7(1.9)	 7.9(2.0)	 7.2(1.9)	 0.525	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
RV	Vebl	(cm/s)	 	 	 	 	
						Birth	 6.1(1.8)	 4.4(1.8)	 4.3(2.3)	 <0.001§§,§§§	
						At	term	 "	 8.9(3.8)	 7.4(3.0)	 <0.001§§§	
						1	month	 11.2(4.2)	 9.7(3.1)	 12.1(4.9)	 0.257	
						1	year	 12.9(4.0)	 11.2(3.2)	 12.6(4.4)	 0.331	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
RV	Vabl	(cm/s)	 	 	 	 	
						Birth	 5.7(1.2)	 5.3(1.2)	 4.5(1.4	 0.002‡‡	
						At	term	 "	 7.0(2.1)	 6.1(1.8)	 0.030	
						1	month	 5.3(1.7)	 6.5(2.0)	 5.5(1.0)	 0.238	
						1	year	 6.4(2.5)	 7.0(2.4)	 6.3(1.4)	 0.627	
						ANOVA	(p-value)	 <0.001	 <0.05	 <0.001	 	
RV	free	wall	mid-segment	longitudinal	peak	systolic	strain,	Ss	(%)	
						Birth	 -27.6(5.8)	 -25.0(5.5)	 -23.2(6.7)	 0.004‡‡	
						At	term	 "	 -34.2(5.1)	 -34.9(5.6)	 <0.001§§,§§§	
						1	month	 -34.2(4.4)	 -34.2(3.7)	 -34.4(5.3)	 0.989	
						1	year	 -40.9(3.9)	 -40.3(3.2)	 -39.1(4.5)	 0.315	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
RV	SRs	(/s)	 	 	 	 	
						Birth	 -2.4(0.7)	 -2.3(0.7)	 -2.2(0.8)	 0.490	
						At	term	 "	 -3.4(0.8)	 -3.5(0.6)	 <0.001§§,§§§	
						1	month	 -4.1(0.9)	 -3.9(1.0)	 -3.5(0.9)	 0.095	
						1	year	 -4.4(1.0)	 -4.5(1.0)	 -3.7(0.9)	 0.032†	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
RV	SRe	(/s)	 	 	 	 	
						Birth	 2.7(0.9)	 2.4(0.8)	 2.8(1.2)	 0.182	
						At	term	 "	 5.0(1.6)	 3.9(1.7)	 <0.001†,‡‡,§§§	
						1	month	 5.8(1.9)	 5.0(1.6)	 5.5(1.9)	 0.359	
						1	year	 6.2(1.2)	 6.1(1.5)	 5.4(1.1)	 0.113	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
RV	SRa	(/s)	 	 	 	 	
						Birth	 2.9(0.9)	 3.1(0.8)	 3.0(1.3)	 0.556	
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						At	term	 "	 5.4(1.1)	 4.2(0.9)	 <0.001‡,§§,§§§	
						1	month	 4.6(1.7)	 3.5(1.0)	 3.6(1.6)	 0.062	
						1	year	 3.9(1.3)	 3.4(1.4)	 2.9(0.9)	 0.077	
						ANOVA	(p-value)	 <0.001	 <0.001	 <0.05	 	
	
RV	Ds’,	right	ventricular	 lateral	annulus	displacement;	RV	Vsbl,	right	ventricular	myocardial	systolic	velocity	at	basal	
lateral	wall;	RV	Vebl,	right	ventricular	myocardial	early	diastolic	velocity	at	basal	lateral	wall;	RV	Vabl,	right	ventricular	
myocardial	late	diastolic	velocity	at	basal	lateral	wall;	RV	Ssl,	right	ventricular	longitudinal	peak	systolic	strain;	RV	SRs,	
right	ventricular	systolic	strain	rate;	RV	SRe,	right	ventricular	early	diastolic	strain	rate;	RV	SRa,	right	ventricular	late	
diastolic	strain	rate.	
Results	are	presented	as	mean(SD).	
§p	<0.001(PT-RDS	v	PTC),	§§p	<0.001(PT-RDS	v	TC),	§§§p	<0.001(PTC	v	TC),		
‡p	<0.01(PT-RDS	v	PTC),	‡‡p	<0.01(PT-RDS	v	TC),	‡‡‡p	<0.01(PTC	v	TC),		
†p	<0.05(PT-RDS	v	PTC),	††p	<0.05(PT-RDS	v	TC),	†††p	<0.05(PTC	v	TC)	
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Table	6:	Surrogate	measures	of	pulmonary	arterial	pressure	
	
	 Term	Control	 PT	Control	 PT-RDS	
ANOVA	
p-value	
PAAT	(ms)	 	 	 	 	
Birth	 70.3(11.9)	 64.2(15.1)	 52.6(11.3)	 <0.001‡,§§	
At	term	 "	 57.3(10.2)	 49.5(11.2)	 <0.001§§,§§§	
1	month	 							61.1(8.9)	 							54.8(6.5)	 							54.2(7.6)	 0.005††,†††	
1	year	 79.5(10.9)	 83.1(10.4)	 84.7(15.8)	 0.316	
ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
RVET	(ms)	 	 	 	 	
Birth	 224.6(20.7)	 208.2(19.7)	 198.1(26.3)	 <0.001§§,‡‡‡	
At	term	 "	 197.4(15.9)	 202.0(15.8)	 <0.001§§,§§§	
1	month	 199.2(16.0)	 193.8(14.9)	 197.4(13.5)	 0.479	
1	year	 236.3(20.2)	 234.6(19.0)	 238.3(24.5)	 0.874	
ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
PAAT:RVET	ratio	 	 	 	 	
Birth	 0.31(0.04)	 0.31(0.06)	 0.27(0.04)	 <0.001‡,§§	
At	term	 "	 0.29(0.06)	 0.25(0.06)	 <0.001†,§§	
1	month	 0.31(0.05)	 0.28(0.03)	 0.27(0.03)	 0.015††	
1	year	 0.34(0.05)	 0.35(0.03)	 0.35(0.05)	 0.287	
ANOVA	(p-value)	 <0.001	 <0.001	 <0.001	 	
PAAT,	pulmonary	artery	acceleration	time;	RVET,	right	ventricular	ejection	time	
Results	are	presented	as	mean(SD).	
§p	<0.001(PT-RDS	v	PTC),	§§p	<0.001(PT-RDS	v	TC),	§§§p	<0.001(PTC	v	TC),		
‡p	<0.01(PT-RDS	v	PTC),	‡‡p	<0.01(PT-RDS	v	TC),	‡‡‡p	<0.01(PTC	v	TC),		
†p	<0.05(PT-RDS	v	PTC),	††p	<0.05(PT-RDS	v	TC),	†††p	<0.05(PTC	v	TC)	
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Figure	legends	
	
Figure	 1:	 Measurement	 of	 LV	 chamber	 length,	 LV	 annular	 displacement	 and	 derivation	 of	 LV	 long	 axis	
shortening.	
	
On	this	static	image,	the	endocardial	border	at	the	apex	is	not	well	defined	but	during	analysis	its	position	
was	determined	by	reviewing	the	cine	loop.	
	
	
Figure	2:	LV	strain	measurement	in	the	middle	segment	of	the	LV	free	wall.	
